Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Interestingly, when they used users of sulphonylureas as the comparator, GLP1-RAs users had a significant elevation in risk of thyroid cancer (weighted HR 1.80, 95% CI 1.282.52)
Under the FTC's Health Breach Notification Rule (16 CFR Part 318, as amended July 2024), health app developers that handle personal health records outside HIPAA's reach are required to notify users and the FTC within 60 days of discovering a breach of unsecured, individually identifiable health information
GSH is the smallest of the intracellular thiols (a compound that contains the functional group composed of a sulphur-hydrogen bond (-SH) hence its unpleasant smell when mercaptans are released) and its high donating electron capacity combined with dense intracellular concentration provides significant oxidative reducing capacity.[3] How can you take it and what are its suggested applications